190 related articles for article (PubMed ID: 35579633)
1. Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood.
Day JW; Elfeky R; Nicholson B; Goodman R; Pearce R; Fox TA; Worth A; Booth C; Veys P; Carpenter B; Hough R; Gaspar HB; Titman P; Ridout D; Workman S; Hernandes F; Sandford K; Laurence A; Campbell M; Burns SO; Morris EC
J Clin Immunol; 2022 Aug; 42(6):1230-1243. PubMed ID: 35579633
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.
Albert MH; Sirait T; Eikema DJ; Bakunina K; Wehr C; Suarez F; Fox ML; Mahlaoui N; Gennery AR; Lankester AC; Beier R; Bernardo ME; Bigley V; Lindemans CA; Burns SO; Carpenter B; Dybko J; Güngör T; Hauck F; Lum SH; Balashov D; Meisel R; Moshous D; Schulz A; Speckmann C; Slatter MA; Strahm B; Uckan-Cetinkaya D; Meyts I; Vallée TC; Wynn R; Neven B; Morris EC; Aiuti A; Maschan A; Aljurf M; Gedde-Dahl T; Gurman G; Bordon V; Kriván G; Locatelli F; Porta F; Valcárcel D; Beguin Y; Faraci M; Kröger N; Kulagin A; Shaw PJ; Veelken JH; Diaz de Heredia C; Fagioli F; Felber M; Gruhn B; Holter W; Rössig C; Sedlacek P; Apperley J; Ayas M; Bodova I; Choi G; Cornelissen JJ; Sirvent A; Khan A; Kupesiz A; Lenhoff S; Ozdogu H; von der Weid N; Rovira M; Schots R; Vinh DC
Blood; 2022 Oct; 140(14):1635-1649. PubMed ID: 35344580
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Second Allogeneic HSCT for Patients with Inborn Errors of Immunity: Retrospective Study of 20 Years' Experience.
Mehta P; Tsilifis C; Lum SH; Slatter MA; Hambleton S; Owens S; Williams E; Flood T; Gennery AR; Nademi Z
J Clin Immunol; 2023 Nov; 43(8):1812-1826. PubMed ID: 37452206
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes.
Llaurador G; Nicoletti E; Prockop SE; Hsu S; Fuller K; Mauguen A; O'Reilly RJ; Boelens JJ; Boulad F
Transplant Cell Ther; 2021 Sep; 27(9):780.e1-780.e14. PubMed ID: 34082161
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis.
Albert MH; Slatter MA; Gennery AR; Güngör T; Bakunina K; Markovitch B; Hazelaar S; Sirait T; Courteille V; Aiuti A; Aleinikova OV; Balashov D; Bernardo ME; Bodova I; Bruno B; Cavazzana M; Chiesa R; Fischer A; Hauck F; Ifversen M; Kałwak K; Klein C; Kulagin A; Kupesiz A; Kuskonmaz B; Lindemans CA; Locatelli F; Lum SH; Maschan A; Meisel R; Moshous D; Porta F; Sauer MG; Sedlacek P; Schulz A; Suarez F; Vallée TC; Winiarski JH; Zecca M; Neven B; Veys P; Lankester AC
Blood; 2022 Mar; 139(13):2066-2079. PubMed ID: 35100336
[TBL] [Abstract][Full Text] [Related]
7. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience.
Morillo-Gutierrez B; Beier R; Rao K; Burroughs L; Schulz A; Ewins AM; Gibson B; Sedlacek P; Krol L; Strahm B; Zaidman I; Kalwak K; Talano JA; Woolfrey A; Fraser C; Meyts I; Müller I; Wachowiak J; Bernardo ME; Veys P; Sykora KW; Gennery AR; Slatter M
Blood; 2016 Jul; 128(3):440-8. PubMed ID: 27216217
[TBL] [Abstract][Full Text] [Related]
8. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
[TBL] [Abstract][Full Text] [Related]
9. BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions.
Burney C; Wadhera K; Breslin P; Pearce R; Wells M; Alajangi R; Protheroe R; Marks DI; Griffin J; Robinson S
Biol Blood Marrow Transplant; 2020 Dec; 26(12):2271-2278. PubMed ID: 32890747
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for a secondary malignancy nearly restores complete chimerism in an SCID-patient after HSCT.
Maier FI; Schulz A; Furlan I; Felgentreff K; Jacobsen EM; Sirin M; Schwarz K; Pannicke U; Stursberg J; Debatin KM; Hönig M
Clin Immunol; 2024 Feb; 259():109891. PubMed ID: 38185266
[TBL] [Abstract][Full Text] [Related]
11. Post-Transplant CD34
Chandra S; Bleesing JJ; Jordan MB; Grimley MS; Khandelwal P; Davies SM; Edwards S; Leemhuis T; Marsh RA
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1527-1529. PubMed ID: 29555312
[TBL] [Abstract][Full Text] [Related]
12. Second allogeneic hematopoietic stem cell transplantation in patients with inborn errors of immunity.
Laberko A; Sultanova E; Idarmacheva A; Skvortsova Y; Shelikhova L; Nechesnyuk A; Kobyzeva D; Shcherbina A; Maschan M; Maschan A; Balashov D
Bone Marrow Transplant; 2023 Mar; 58(3):273-281. PubMed ID: 36456809
[TBL] [Abstract][Full Text] [Related]
13. The impact of Treosulfan-based conditioning for inborn errors of immunity: Is dose monitoring crucial?
Ersoy GZ; Çipe F; Fışgın T; Aksoy BA; Öner ÖB; Hashemi N; Aydoğdu S; Erdem M; Dikme G; Murat K; Bozkurt C
Clin Transplant; 2023 Sep; 37(9):e15083. PubMed ID: 37534623
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity.
Nicholson B; Goodman R; Day J; Worth A; Carpenter B; Sandford K; Morris EC; Burns SO; Ridout D; Titman P; Campbell M
J Clin Immunol; 2022 Oct; 42(7):1451-1460. PubMed ID: 35723794
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.
Cuvelier GD; Rubin TS; Wall DA; Schroeder ML
J Clin Immunol; 2016 Oct; 36(7):713-24. PubMed ID: 27438785
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
Allewelt H; Martin PL; Szabolcs P; Chao N; Buckley R; Parikh S
Pediatr Blood Cancer; 2015 Dec; 62(12):2216-22. PubMed ID: 26291959
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimen: A Pilot Phase II Study.
Wang L; Wang LN; Zhou JF; Gao WH; Jiang CH; Tang W; Zhao WL; Hu J; Jiang JL
Front Med (Lausanne); 2021; 8():627946. PubMed ID: 33708780
[TBL] [Abstract][Full Text] [Related]
18. Curative allogeneic hematopoietic stem cell transplantation following reduced toxicity conditioning in adults with primary immunodeficiency.
Marçais A; Mahlaoui N; Neven B; Lanternier F; Catherinot É; Salvator H; Cheminant M; Jeljeli M; Asnafi V; van Endert P; Couderc LJ; Lortholary O; Picard C; Moshous D; Hermine O; Fischer A; Suarez F
Bone Marrow Transplant; 2022 Oct; 57(10):1520-1530. PubMed ID: 35794259
[TBL] [Abstract][Full Text] [Related]
19. Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells.
Grimaldi F; Potter V; Perez-Abellan P; Veluchamy JP; Atif M; Grain R; Sen M; Best S; Lea N; Rice C; Pagliuca A; Mufti GJ; Marsh JCW; Barber LD
Biol Blood Marrow Transplant; 2017 Feb; 23(2):293-299. PubMed ID: 27816648
[TBL] [Abstract][Full Text] [Related]
20. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
